{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:18:32Z","timestamp":1649074712421},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.cardfail.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T12:25:47Z","timestamp":1322828747000},"page":"990-992","source":"Crossref","is-referenced-by-count":1,"title":["Controlling the Flood Gates: Vaptans, Furosemide and the Quest for a Renal Protective Diuresis"],"prefix":"10.1016","volume":"17","author":[{"given":"Lisa C.","family":"Costello-Boerrigter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John C.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2011.10.002_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2011.10.002_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrcardio.2011.74","article-title":"Heart failure: furosemide\u2014to DOSE or not to DOSE, that is the question","volume":"8","author":"Costello-Boerrigter","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2011.10.002_bib3","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cardfail.2011.08.012","article-title":"Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure","volume":"17","author":"Goldsmith","year":"2011","journal-title":"J Cardiac Failure"},{"key":"10.1016\/j.cardfail.2011.10.002_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2011.08.005","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction","volume":"17","author":"Udelson","year":"2011","journal-title":"J Cardiac Failure"},{"key":"10.1016\/j.cardfail.2011.10.002_bib5","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","article-title":"Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure","volume":"290","author":"Costello-Boerrigter","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cardfail.2011.10.002_bib6","doi-asserted-by":"crossref","first-page":"F1115","DOI":"10.1152\/ajprenal.00337.2002","article-title":"Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cardfail.2011.10.002_bib7","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2011.10.002_bib8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2011.10.002_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.2000.80.1.277","article-title":"Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy","volume":"80","author":"Reilly","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cardfail.2011.10.002_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/CIRCHEARTFAILURE.109.916114","article-title":"Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure","volume":"3","author":"Costello-Boerrigter","year":"2010","journal-title":"Circ Heart Failure"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916411012012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916411012012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T05:32:34Z","timestamp":1561008754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916411012012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1071916411012012"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2011.10.002","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}